Vimarsana
Biggest News Aggregation in the World

Page 46 - Behavioral Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Behavioral Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Behavioral Therapy Today - Breaking & Trending Today

Get Happy: The Science Of Emotions And How To Harness Them For Happiness - Vimarsana News

Get Happy: The Science Of Emotions And How To Harness Them For Happiness

Emotions matter and can help you move forward as you transition back to something closer to your pre-pandemic life and renew, refresh and (perhaps) reinvent your approaches.

Source: forbes.com
Top 11 Stress Management Techniques - Vimarsana News

Top 11 Stress Management Techniques

There are quite a number of stress management techniques that aim to reduce how much stress affects an individual in daily life.

Source: hngn.com
One Major Side Effect of Drinking Too Much Coffee, Says Science - Vimarsana News

One Major Side Effect of Drinking Too Much Coffee, Says Science

One Major Side Effect of Drinking Too Much Coffee, Says Science © Provided by Eat This, Not That! woman wearing glasses and drinking coffee For many people, drinking a cup of coffee in the morning is an essential part of their day. And while the occasional cup of coffee may boost your energy level, focus, or even your mood, you can definitely have too much of a good thing when it comes to your coffee intake. While the U.S. Food&Drug Administration (FDA) says that most healthy adults can safely consume up to 400 milligrams of caffeine each day—the amount you'd get in approximately four t...

Source: msn.com
How to handle anxiety - Vimarsana News

How to handle anxiety

One of the most common mental illness is social anxiety and anxiety.

Source: pulse.ng
Semaglutide in people with obesity: boosts wellbeing and ability to perform daily physical activities - Vimarsana News

Semaglutide in people with obesity: boosts wellbeing and ability to perform daily physical activities

Share this article Share this article BAGSVÆRD, Denmark, May 13, 2021 /PRNewswire/ -- Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with semaglutide 2.4 mg. The trial showed that treatment with once-weekly semaglutide 2.4 mg led to significant improvements in physical functioning, such as climbing stairs and tying your shoes, and beneficial effects on weight related and health related quality of life scores (HRQoL) compared to placebo.* Following the 68-week ...